BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 17988302)

  • 1. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary swelling and a reduced general condition in a middle-aged man.
    Klimm B; Engert A; Diehl V;
    Nat Clin Pract Oncol; 2004 Nov; 1(1):51-4; quiz 1 p following 54. PubMed ID: 16264800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma with cutaneous involvement.
    Hsia CC; Howson-Jan K; Rizkalla KS
    Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
    Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
    Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
    Kobayashi K; Yokote T; Akioka T; Hara S; Oka S; Hiraoka N; Hirata Y; Miyoshi T; Tsuji M; Hanafusa T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1327-30. PubMed ID: 17687225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splenic marginal zone B-cell lymphoma with bilateral renal invasion after splenectomy].
    Hoshino T; Iriuchijima H; Ogawa Y; Irisawa H; Jinbo T
    Rinsho Ketsueki; 2008 Jan; 49(1):35-9. PubMed ID: 18277594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
    Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
    Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
    Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
    Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary non-Hodgkin's lymphoma of the esophagus following Hodgkin's disease].
    Fernández-Llamazares J; de la Cruz J; Bianchi A; Ribera JM
    Med Clin (Barc); 1999 Mar; 112(9):356-7. PubMed ID: 10220770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hodgkin's disease presenting with progressive liver failure].
    Nohgawa M; Yonetani N; Sugiyama T
    Rinsho Ketsueki; 2002 Sep; 43(9):857-61. PubMed ID: 12412292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
    Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma.
    Parekh V; Peker D
    J Clin Pathol; 2015 Nov; 68(11):947-50. PubMed ID: 26193900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
    Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
    Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Floral leukemic cells transformed from marginal zone lymphoma.
    Chang ST; Hsieh YC; Lu YH; Tzeng CC; Lin CN; Chuang SS
    Pathol Res Pract; 2008; 204(1):23-6. PubMed ID: 17913385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma].
    Takashima H; Kawashima K; Isayama Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1172-4. PubMed ID: 14978934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of marginal zone lymphoma involving bone marrow.
    Kent SA; Variakojis D; Peterson LC
    Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.